Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Clin J Gastroenterol ; 9(6): 341-344, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27730597

ABSTRACT

Acute esophageal necrosis (AEN) or "black esophagus" is a rare condition presented by patients with critical state of health and characterized by a darkened esophagus, usually the distal third, in upper digestive endoscopy. The main clinical manifestation is upper gastrointestinal bleeding and there may be abdominal pain, dysphagia, nausea, vomiting, fever and syncope associated. The diagnosis depends on clinical suspicion and performing endoscopy, the biopsy not being required. In this article we present a case of a patient who had lots of comorbidities and developed AEN during a post-operative period, and discuss the importance of AEN in an increasingly ageing population.


Subject(s)
Esophagus/pathology , Acute Disease , Adenocarcinoma/surgery , Esophagoscopy , Female , Humans , Middle Aged , Necrosis/diagnosis , Postoperative Complications/diagnosis , Rectal Neoplasms/surgery
2.
Int J Colorectal Dis ; 27(2): 249-55, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21845417

ABSTRACT

PURPOSE: Although colorectal cancer is typical in the older population, tumor onset before age 40 is not infrequent. However, the behavior, characteristics, and prognosis of this disease in young patients are unclear when compared to the older population. It is believed that young patients have a poor prognosis. We hypothesized that young patients have a poor prognosis because they have advanced-stage cancer with more aggressive pathologic features. METHODS: Using a university hospital database, we analyzed the histopathological features of three groups of patients with a diagnosis of colorectal cancer: young age group (patients 40 years and younger), intermediate age group (patients 41-80 years old), and old age group (patients 81 years and older). RESULTS: A total of 653 cases of colorectal cancer were analyzed. The young age group comprised 48 patients (7.4%), the intermediate age group comprised 538 patients (82.4%) and the old age group consisted of 67 patients (10.3%).The gender distribution was similar between the groups. The mean age of the young, intermediate, and old age groups were 34.5 (±5.0), 61.7 (±11.1) and 85.1 (±4.6) years old, respectively. The pathological features analyzed such as lymph node involvement, tumor histological classification and grade, venous, neural and lymphatic invasion, T and N classification of the TNM System, and Astler-Coller classification were similar between the age groups. CONCLUSIONS: The colorectal histopathological features in young patients are similar to older patients. More aggressive characteristics or more advanced stage are not seen in younger patients.


Subject(s)
Colorectal Neoplasms/epidemiology , Colorectal Neoplasms/pathology , Adult , Age Distribution , Age Factors , Aged , Aged, 80 and over , Brazil/epidemiology , Female , Humans , Male , Middle Aged , Neoplasm Grading
3.
Surg Today ; 41(12): 1644-8, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21969199

ABSTRACT

This report presents two cases of young males who developed the rare idiopathic form of sclerosing encapsulating peritonitis (SEP) presented as partial bowel obstruction, both diagnosed during surgical treatment, with satisfactory outcomes. Sclerosing encapsulating peritonitis is a rare and enigmatic condition, characterized by intraperitoneal fibrosclerosis, which causes intestinal obstruction. It is a chronic entity with a poorly elucidated pathophysiology, leading to the constitution of a thick white nacreous fibrosis membrane that wraps the bowel in a concertina-like fashion with some adhesions configuring an intra-abdominal cocoon. Sclerosing encapsulating peritonitis is reported in a wide variety of patients, including those who have undergone peritoneal dialysis, young adolescent girls, cirrhotic patients after peritoneal-venous shunting, and patients treated with ß-blockers. Nevertheless, the etiology of SEP remains obscure. This entity presents many difficulties in preoperative diagnosis because of its peculiar characteristics. Recognition of the SEP results in proper management and prevents unnecessary bowel resection. Regardless of cause, the treatment of the obstruction is surgical, with dissection of the encasing membrane from the intestine and separation of adherent loops of small bowel until they are laid free and returned to their normal configuration. The prognosis after appropriate surgical therapy is good, but depends on coexisting diseases.


Subject(s)
Intestinal Obstruction/etiology , Intestines/pathology , Peritonitis/etiology , Adult , Fibrosis , Humans , Intestinal Obstruction/surgery , Intestines/surgery , Male , Peritoneum/pathology , Peritoneum/surgery , Peritonitis/surgery , Sclerosis/complications
4.
Rev Col Bras Cir ; 37(1): 17-22, 2010 Feb.
Article in Portuguese | MEDLINE | ID: mdl-20414571

ABSTRACT

OBJECTIVE: To study was to investigate the associated morbidity and mortality of the restoration of intestinal continuity after Hartmann's procedure. METHODS: Hospital records of 29 patients undergoing surgery to restoration of intestinal continuity after Hartmann's procedure at Hospital das Clínicas da Universidade Federal de Minas Gerais between January 1998 and December 2006 were retrospectively analyzed. Demographic, morbidity and mortality data were colleted. RESULTS: There were 16 men and 13 women with mean age of 52.6 years. The median time between the Hartmann's procedure and the attempt of closure of colostomy was 17.6 months (range,1-84 months). The median operation time was 300 minutes (range, 180-720 min). The restoration of the continuity was successful in 27 patients (93%). Two patients had anastomotic leakage (7%) and 7 had wound infection (22%). The mortality rate was of 3.4% (1/29 patients). There were association between unsuccessful restoration of intestinal continuity and previous attempt of closure (p=.007), chemotherapy (p=.037) and long term stay with colostomy (p =.007). CONCLUSION: The interval between the Hartmann's procedure and the restoration of intestinal continuity should not be long. The patients should be aware that in some circumstances the restoration of intestinal continuity after Hartmann's procedure is not possible due to local conditions of the rectum.


Subject(s)
Colostomy/methods , Intestine, Large/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Retrospective Studies , Young Adult
6.
Toxicon ; 48(5): 543-9, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16926041

ABSTRACT

Scorpion venom (TX) promotes gastric acid and pepsin secretion leading to acute gastric mucosal lesions (AGML), when injected in animals. The goal of the present study was to observe the effects of acid gastric secretion blockers over the incidence of TX-induced AGML in vivo. To verify this model, we used male albino rats, fasted 18-20 h (n=122) and anaesthetized with urethane (1.4 g/kg, i.p.). Their trachea and left femoral vein were both cannulated; the first to avoid airway obstructions during scorpion intoxication and the second for administration of saline, TX and acid blockers. Following the surgical procedure, the animals were divided in 10 groups of at least 10 animals each. Control groups were injected with NaCl 0.9% 1 ml/kg (n=10) or TX 375 microg/kg (n=32). Test groups (n=10, each) received atropine 5 mg/kg, cimetidine 10mg/kg, ranitidine 2.5mg/kg, ranitidine 5mg/kg, omeprazol 1 mg/kg, omeprazol 4 mg/kg, octreotide 80 and octreotide 100 microg/kg 10 min before the TX was injected. After 1h of intoxication, the stomach was resected for macroscopic study and the gastric secretion was collected for volume, pH and acid output assessment. We observed that all blockers were able to completely or partially prevent the TX-induced acid secretion as well as the AGML (p<0.05). Our data suggest the TX-induced AGML can be prevented by different class of acid blockers injected before the intoxication.


Subject(s)
Gastric Acid/metabolism , Gastric Mucosa/drug effects , Gastrointestinal Agents/pharmacology , Neurotoxins/toxicity , Scorpion Venoms/toxicity , Stomach Diseases/prevention & control , Acute Disease , Anesthesia , Animals , Atropine/pharmacology , Cimetidine/pharmacology , Dose-Response Relationship, Drug , Drug Antagonism , Enzyme Inhibitors/pharmacology , Gastric Mucosa/metabolism , Gastric Mucosa/pathology , Male , Neurotoxins/analysis , Octreotide/pharmacology , Omeprazole/pharmacology , Pepsin A/metabolism , Ranitidine/pharmacology , Rats , Scorpion Venoms/analysis , Stomach Diseases/chemically induced , Stomach Diseases/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...